What to Know About GLP-1 Medications and Weight Management Programs
Learn how Eden connects patients to licensed providers to explore GLP-1 medications as part of medical weight management programs.
Discover how semaglutide may affect your menstrual cycle, including irregular periods, hormonal shifts, and what to discuss with your licensed healthcare provider.
Semaglutide does not directly affect reproductive hormones, but its impact on metabolic function—including reduced insulin resistance and weight loss—may indirectly regulate menstrual cycles. These changes are particularly relevant for women with conditions such as polycystic ovary syndrome (PCOS), which may involve disrupted ovulation due to insulin resistance.
Semaglutide may influence the menstrual cycle in two ways:
Weight loss-related hormone shifts may lead to transient changes in vaginal discharge and moisture. These effects may stabilize as hormone levels rebalance.
See HealthCentral’s report on vaginal health and GLP-1 therapy
As semaglutide supports weight reduction, patients may experience:
These may affect symptom perception during the cycle even if hormone levels remain stable.
Review UCLA Health’s findings on semaglutide and weight loss
Semaglutide may influence several hormone systems:
These changes may be gradual and should be monitored by a licensed healthcare provider for clinical significance.
See Business Insider’s report on semaglutide use in PCOS patients
Use a journal or digital app to monitor:
These logs are helpful for your licensed healthcare provider to assess trends and hormone response.
If your cycle becomes highly irregular or you experience:
Then schedule a hormone panel or follow-up appointment. Thyroid and insulin markers may also be assessed.
These behaviors improve hormonal feedback loops and reproductive health outcomes.
Eden offers medically supervised GLP-1 treatment plans that include:
Start your GLP-1 consultation through Eden
This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before changing medications or interpreting cycle changes.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Yes, particularly during the first few months or during rapid weight changes. Most cycle changes normalize over time.
Possibly. Improved insulin sensitivity and reduced fat mass may promote ovulation and cycle regulation in PCOS patients.
Not unless directed by your licensed healthcare provider. Most menstrual changes are temporary. Keep a log and discuss it during your next appointment.
It may impair the absorption of oral contraceptives due to delayed gastric emptying. Consider backup contraception if needed.
Compounded GLP-1 medications may be used legally during FDA-recognized shortages when prescribed by a licensed healthcare provider and filled by FDA-registered, state-licensed compounding pharmacies. While not FDA-approved, these medications can be safe when prepared under strict quality and sterility standards.
Eden partners only with vetted pharmacies that meet applicable federal and state requirements, including USP <797> sterile compounding guidelines. Always discuss risks and benefits with your licensed healthcare provider before starting compounded treatment.